Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Mar 2, 2026 · 10-K · 61 days after period end · 0001493152-26-008564
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$684.64K | -$1.52M | -$1.55M | $893.46K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 2, 2026 · 61 d after period end
